GSK-3
β inhibitor VIII, N-(4-methoxybenzyl)-N′-(5-nitro-1,3-thiazol-2-yl)urea, was purchased from Calbiochem (San Diego, CA, USA).
Cell Counting Kit-8 (CCK-8) was from Dojindo (Tokyo, Japan).
Mitochondria isolation kit for cultured cells and
RIPA buffer were obtained from Thermo Scientific (Rockford, IL, USA).
Annexin V and
propidium iodide (PI) for flow cytometry were purchased from BD Pharmingen (San Diego, CA, USA). For the Western blot, the following specific antibodies were used:
anti-tau (Invitrogen, Carlsbad, CA, USA), anti-phospho-tau (Ser396) (Invitrogen, Carlsbad, CA, USA),
anti-Fas (Santa Cruz Biotech, Delaware, CA, USA),
anti-Fas ligand (Santa Cruz Biotech, Delaware, CA, USA), anti-cleaved caspase-8 (Novus Biologicals, Littleton, CO, USA), anti-p38
α (Santa Cruz Biotech, Delaware, CA, USA),
anti-Daxx (Cell signaling, Beverly, MA, USA),
anti-cleaved caspase-3 (Cell Signaling, Beverly, MA, USA), and
anti-cytochrome C (Cell Signaling, Beverly, MA, USA).
Kim J.E., Lim J.H., Jeon G.S., Shin J.Y., Ahn S.W., Kim S.H., Lee K.W., Hong Y.H, & Sung J.J. (2017). Extrinsic Apoptosis Pathway Altered by Glycogen Synthase Kinase-3β Inhibitor Influences the Net Drug Effect on NSC-34 Motor Neuron-Like Cell Survival. BioMed Research International, 2017, 4163839.